Ice Neurosystems, Inc.
Developer of an integrated neuromonitoring platform that combines continuous EEG and bedside physiological data with cloud-based tele-ICU access and embedded clinical decision support. The company designs single-use subcutaneous electrode arrays intended for deployment by routine clinical staff, and has pursued FDA 510(k) clearances and emergency use authorization for its devices and software. Target users are hospitals and clinical teams caring for critically ill patients at risk for brain injury.
Industries
N/A
Nr. of Employees
small (1-50)
Patents
Systems and methods for optimizing the bedside insertion and recording function of subgaleal electrode arrays for short-term hemispheric brain monitoring
US-11369303-B2
View Details
Systems and methods for optimizing the bedside insertion and recording function of subgaleal electrode arrays for short-term hemispheric brain monitoring
US-11369303-B2
View DetailsProducts
Integrated neuromonitoring platform for continuous EEG
Bedside and cloud software that collects, integrates, processes and visualizes continuous EEG and high-frequency physiological data with embedded clinical decision support.
Single-use subcutaneous electrode arrays (510(k)-cleared)
Minimally invasive electrodes placed beneath the scalp for multi-day continuous EEG monitoring; intended for deployment by routine clinical personnel.
Integrated neuromonitoring platform for continuous EEG
Bedside and cloud software that collects, integrates, processes and visualizes continuous EEG and high-frequency physiological data with embedded clinical decision support.
Single-use subcutaneous electrode arrays (510(k)-cleared)
Minimally invasive electrodes placed beneath the scalp for multi-day continuous EEG monitoring; intended for deployment by routine clinical personnel.
Services
Web-based access to de-identified bedside EEG and physiological data for remote review and clinician collaboration.
Web-based access to de-identified bedside EEG and physiological data for remote review and clinician collaboration.
Expertise Areas
- Continuous EEG monitoring (cEEG) for critical care
- Subcutaneous electrode design and clinical deployment
- Neuromonitoring platform software and cloud tele-ICU
- Clinical decision support for neurocritical care
Key Technologies
- Continuous electroencephalography (cEEG)
- Subcutaneous electrode arrays
- Cloud-based clinical data platform
- Clinical decision support algorithms
News & Updates
Named to the inaugural American Heart Association Heart and Brain Health Accelerator (selection from large applicant pool).
Selected for the 2024 MedTech Innovator program cohort.
FDA granted 510(k) clearance for subcutaneous electrode arrays used for continuous monitoring (March 2021; subsequent clearances for device iterations noted in timeline).
FDA granted 510(k) clearance for the neuromonitoring software platform.
FDA granted Emergency Use Authorization for use of the neuromonitoring platform with subcutaneous electrodes during the COVID-19 pandemic.
Completed a trial evaluating subcutaneous electrodes in patients with cardiac arrest.
Named to the inaugural American Heart Association Heart and Brain Health Accelerator (selection from large applicant pool).
Selected for the 2024 MedTech Innovator program cohort.
FDA granted 510(k) clearance for subcutaneous electrode arrays used for continuous monitoring (March 2021; subsequent clearances for device iterations noted in timeline).
FDA granted 510(k) clearance for the neuromonitoring software platform.
FDA granted Emergency Use Authorization for use of the neuromonitoring platform with subcutaneous electrodes during the COVID-19 pandemic.
Completed a trial evaluating subcutaneous electrodes in patients with cardiac arrest.